December, 2024
December 2024
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
3031  
Lumír Kunovský: Pancreas2000 project
Jun 26, 2024, 16:21

Lumír Kunovský: Pancreas2000 project

Recently Lumír Kunovský, Associate Professor at the University Hospital Brno, shared a post on X about a recent paper by Kasper Overbeek et al. titled “Type 1 Autoimmune Pancreatitis in Europe: Clinical Profile and Response to Treatment” published in CGH:

Image

Lumír Kunovský commented on X sharing the paper:

Pancreas2000 project.

  • Type 1 Autoimmune Pancreatitis in Europe
  • Clinical Profile and Response to Treatment

in Clinical Gastroenterology and Hepatology (CGH)

EPC2024
Date: June 26-29, 2024

Figure 1

Complete remission stratified on elevation of IgG4 level.

Image

Remission stratified for the different steroid remission induction treatment or no treatment.

  • Complete remission: absence of clinical symptoms and resolution of radiologic abnormalities attributed to AIP.
  • Partial remission: either absence of symptoms or resolution of radiol abnormal.

Image

Conclusions

  • Patients with type 1 AIP and elevated IgG4 level may need closer monitoring.
  • For remission induction, a starting dose of 0.4 mg/kg/day for 2 weeks followed by a short taper period seems effective.”

Image

Source: Lumír Kunovský/X